Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer

Edyta M. Urbanska; Jens B. Sørensen; Linea C. Melchior; Junia C. Costa; Eric Santoni-Rugiu

doi:10.1200/PO.22.00040

Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer

Edyta M. Urbanska, Jens B. Sørensen, Linea C. Melchior, Junia C. Costa, Eric Santoni-Rugiu

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

23 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	e2200040
Tidsskrift	JCO Precision Oncology
Vol/bind	6
Udgave nummer	6
Antal sider	6
ISSN	2473-4284
DOI	https://doi.org/10.1200/PO.22.00040
Status	Udgivet - 2022

Adgang til dokumentet

10.1200/PO.22.00040Licens: CC BY-NC-ND

FulltextForlagets udgivne version, 678 KBLicens: CC BY-NC-ND

Citationsformater

Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer. / Urbanska, Edyta M.; Sørensen, Jens B.; Melchior, Linea C. et al.
I: JCO Precision Oncology, Bind 6, Nr. 6, e2200040, 2022.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{4d75f6bf27e44cee92c7395b89e59986,

title = "Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer",

author = "Urbanska, {Edyta M.} and S{\o}rensen, {Jens B.} and Melchior, {Linea C.} and Costa, {Junia C.} and Eric Santoni-Rugiu",

year = "2022",

doi = "10.1200/PO.22.00040",

language = "English",

volume = "6",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

number = "6",

}

TY - JOUR

T1 - Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non–Small-Cell Lung Cancer

AU - Urbanska, Edyta M.

AU - Sørensen, Jens B.

AU - Melchior, Linea C.

AU - Costa, Junia C.

AU - Santoni-Rugiu, Eric

PY - 2022

Y1 - 2022

U2 - 10.1200/PO.22.00040

DO - 10.1200/PO.22.00040

M3 - Journal article

C2 - 35797511

SN - 2473-4284

VL - 6

JO - JCO Precision Oncology

JF - JCO Precision Oncology

IS - 6

M1 - e2200040

ER -